By Christopher Kuo
TransMedics shares plummeted after the company posted first-quarter profit and revenue that missed Wall Street's forecast.
Shares of the medical technology company fell 21% in after-hours trading on Tuesday to $75.03. The company's shares closed at $94.93. The stock is down 22% year to date.
The company posted a profit of $7.3 million, or 20 cents a share, compared with $25.7 million, or 70 cents a share, a year earlier.
Adjusted earnings were 30 cents a share, missing estimates of 62 cents, according to analysts polled by FactSet.
Revenue rose to $173.9 million from $143.5 million a year earlier. Analysts expected revenue of $174.5 million.
Write to Christopher Kuo at chris.kuo@wsj.com
(END) Dow Jones Newswires
May 05, 2026 18:01 ET (22:01 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments